Tarek El-Toukhy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tarek El-Toukhy has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
Yacoub Khalaf
7 shared publicationsArri Coomarasamy
Academic Department , University of Birmingham , Birmingham , UK
4 shared publicationsPeter Braude
4 shared publications- Peter Braude
King’s College London, St. Thomas’ Hospital
4 shared publications A. Taylor
Assisted Conception Unit, Guy’s and St. Thomas’ Hospital NHS Trust, and
3 shared publicationsJyotsna Pundir
Assisted Conception Unit, 11th Floor, Tower Wing, Guy's and St Thomas NHS Trust, London, UK
3 shared publications
Latest Publications
- 6 February 2024
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 131 (7) , 898
Diagnostic criteria for unexplained infertility: A timely international consensus is crucial
Linked article: This is a mini commentary on Raperport et al, pp. 880‐897 in this issue. To view this article visit https://doi.org/10.1111/1471‐0528.17697.
- 6 February 2024
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 131 (7) , 898
Diagnostic criteria for unexplained infertility: A timely international consensus is crucial
Linked article: This is a mini commentary on Raperport et al, pp. 880‐897 in this issue. To view this article visit https://doi.org/10.1111/1471‐0528.17697.
- 21 December 2022
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 130 (5) , 442
Clinical research into male reproductive health: The road ahead
- 21 December 2022
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 130 (5) , 442
Clinical research into male reproductive health: The road ahead
- Open Access
- 1 March 2021
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 128 (4) , 666
Prevalence of endometriosis: how close are we to the truth?
- 1 March 2021
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 128 (4) , 666
Open AccessPrevalence of endometriosis: how close are we to the truth?
- Open Access
- 30 July 2020
- Published by Wiley
MC on BJOG-20-0227.R2 Prevalence of Endometriosis: how close are we to the truth?
Endometriosis is a common health condition affecting women of reproductive age who often present with chronic pelvic pain and/or infertility. There is wide variation in the estimates of endometriosis prevalence. Accurate reporting of the disease prevalence is hampered by multiple factors including long delay in diagnosis due to natural fluctuation in symptoms severity, lack of a reliable non-surgical diagnostic tool, polymorphic appearance of endometriosis lesions at laparoscopy, inability to achieve histological confirmation is all suspected cases and tendency for disease recurrence. Therefore, a longitudinal, rather than cross-sectional, cohort study design spanning an extended follow-up period is better suited to assess endometriosis prevalence. In this issue of BJOG, Rowlands and colleagues (2020) linked longitudinal survey data to three administrative health databases to identify the prevalence of endometriosis among 13,508 young Australian women followed up for nearly 20 years. The study reported a 6% cumulative prevalence of clinically-confirmed endometriosis and an additional 5.4% of clinically-suspected endometriosis. If these figures reflect the true prevalence of endometriosis, then one in nine women will be diagnosed with endometriosis at some point during their reproductive years up to the age of 44 with a peak at 30-34 years, thus underscoring the significant impact of the disease on the well-being and quality of life in young women and the enormous burden on healthcare resources needed to diagnose and treat endometriosis and its sequelae.The data presented in the study of Rowlands and colleagues (BJOG 2020) included patients who could have been diagnosed with adenomyosis but their condition was coded as endometriosis. This is unlikely to have significantly over-estimated the prevalence of endometriosis as recent evidence suggests adenomyosis prevalence to be only 1% with a considerable proportion of those patients having co-existing endometriosis (Yu et al, Am J Obstet Gynecol 2020; 223: 94.e1-10). The same can not be said about the 5.4% of clinically-suspected endometriosis cases. Symptoms review, clinical examination and various imaging modalities, including ultrasound scanning and magnetic resonance imaging, represent the cornerstone of non-invasive diagnosis of endometriosis. Current evidence suggests that the predictive accuracy of those non-invasive methods in the diagnosis of endometriosis compared to laparoscopy and histological confirmation is modest (Nisenblat et al, Cochrane Database Syst Rev, 2016 (2): CD009591) and depends on the combination of diagnostic tools used as well as the site and extent of the endometriosis lesions (Reid et al, Eur J Obstet Gynecol Reprod Biol 2019; 234: 171-178). These data are not provided in the study of Rowlands and colleagues. It is therefore difficult to accurately estimate the prevalence of endometriosis whether it’s the 6% clinically-confirmed rate or the full 11.4% confirmed and suspected rate. The truth probably lies somewhere in the middle! Future epidemiological studies should endeavour to elucidate on the distinction between the different methods used in the diagnosis of endometriosis with reference to the predictive accuracy of each diagnostic modality to help advance our understanding of the incidence and risk factors associated with this debilitating gynaecological condition.Mr. Tarek A El-ToukhyAssisted Conception Unit, Guys and St. Thomas Hospital NHS Trust11th Floor, Tower Wing,Guys Hospital,St. Thomas Street tarekeltoukhy@hotmail.com
- 30 July 2020
- Published by Wiley
Open AccessMC on BJOG-20-0227.R2 Prevalence of Endometriosis: how close are we to the truth?
Endometriosis is a common health condition affecting women of reproductive age who often present with chronic pelvic pain and/or infertility. There is wide variation in the estimates of endometriosis prevalence. Accurate reporting of the disease prevalence is hampered by multiple factors including long delay in diagnosis due to natural fluctuation in symptoms severity, lack of a reliable non-surgical diagnostic tool, polymorphic appearance of endometriosis lesions at laparoscopy, inability to achieve histological confirmation is all suspected cases and tendency for disease recurrence. Therefore, a longitudinal, rather than cross-sectional, cohort study design spanning an extended follow-up period is better suited to assess endometriosis prevalence. In this issue of BJOG, Rowlands and colleagues (2020) linked longitudinal survey data to three administrative health databases to identify the prevalence of endometriosis among 13,508 young Australian women followed up for nearly 20 years. The study reported a 6% cumulative prevalence of clinically-confirmed endometriosis and an additional 5.4% of clinically-suspected endometriosis. If these figures reflect the true prevalence of endometriosis, then one in nine women will be diagnosed with endometriosis at some point during their reproductive years up to the age of 44 with a peak at 30-34 years, thus underscoring the significant impact of the disease on the well-being and quality of life in young women and the enormous burden on healthcare resources needed to diagnose and treat endometriosis and its sequelae.The data presented in the study of Rowlands and colleagues (BJOG 2020) included patients who could have been diagnosed with adenomyosis but their condition was coded as endometriosis. This is unlikely to have significantly over-estimated the prevalence of endometriosis as recent evidence suggests adenomyosis prevalence to be only 1% with a considerable proportion of those patients having co-existing endometriosis (Yu et al, Am J Obstet Gynecol 2020; 223: 94.e1-10). The same can not be said about the 5.4% of clinically-suspected endometriosis cases. Symptoms review, clinical examination and various imaging modalities, including ultrasound scanning and magnetic resonance imaging, represent the cornerstone of non-invasive diagnosis of endometriosis. Current evidence suggests that the predictive accuracy of those non-invasive methods in the diagnosis of endometriosis compared to laparoscopy and histological confirmation is modest (Nisenblat et al, Cochrane Database Syst Rev, 2016 (2): CD009591) and depends on the combination of diagnostic tools used as well as the site and extent of the endometriosis lesions (Reid et al, Eur J Obstet Gynecol Reprod Biol 2019; 234: 171-178). These data are not provided in the study of Rowlands and colleagues. It is therefore difficult to accurately estimate the prevalence of endometriosis whether it’s the 6% clinically-confirmed rate or the full 11.4% confirmed and suspected rate. The truth probably lies somewhere in the middle! Future epidemiological studies should endeavour to elucidate on the distinction between the different methods used in the diagnosis of endometriosis with reference to the predictive accuracy of each diagnostic modality to help advance our understanding of the incidence and risk factors associated with this debilitating gynaecological condition.Mr. Tarek A El-ToukhyAssisted Conception Unit, Guys and St. Thomas Hospital NHS Trust11th Floor, Tower Wing,Guys Hospital,St. Thomas Street tarekeltoukhy@hotmail.com
- 1 April 2020
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 40 (4) , 604
Adjustment for non-confounders could increase systematic error
- 1 April 2020
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 40 (4) , 604
Adjustment for non-confounders could increase systematic error
- Open Access
- 31 January 2020
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 127 (6) , 719
Clinical application of PGT‐A: is the price too high?
- 31 January 2020
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 127 (6) , 719
Open AccessClinical application of PGT‐A: is the price too high?
- 1 March 2019
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 38 (3) , 481
Double stimulation in poor responders: a cause for concern?
- 1 March 2019
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 38 (3) , 481
Double stimulation in poor responders: a cause for concern?
- 1 February 2018
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 125 (3) , 335
Treatment of post-caesarean niche: the accumulation of evidence
- 1 February 2018
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 125 (3) , 335
Treatment of post-caesarean niche: the accumulation of evidence
- 1 July 2014
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 29 (1) , 141
Response: The overlooked endometrial injury underlying hysteroscopy procedures
- 1 July 2014
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 29 (1) , 141
Response: The overlooked endometrial injury underlying hysteroscopy procedures
- 1 July 2014
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 29 (1) , 143
Response: Hysteroscopy prior to a first IVF treatment cycle: the need for well-performed RCT
- 1 July 2014
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 29 (1) , 143
Response: Hysteroscopy prior to a first IVF treatment cycle: the need for well-performed RCT